Magellan LongevityReviews podcast › Nortriptyline
M
Magellan Longevity Reviews

Nortriptyline — research review 1

A short, evidence-grounded conversation about Nortriptyline and its place in longevity science.

Speaker 1
...and this brings us to nortriptyline. It’s a tricyclic antidepressant often used for pain, particularly neuropathic pain. While it can offer significant relief, we need to look at the evidence regarding its long-term effects on aging and mortality.
Speaker 2
Exactly. The benefit of pain relief is crucial, as chronic pain itself can accelerate biological aging. We see this, for instance, in a study in GeroScience from 2025, showing painful diabetic neuropathy is linked to accelerated epigenetic aging and telomere shortening.
Speaker 1
So, treating pain is vital. However, nortriptyline belongs to a class of drugs with anticholinergic properties. And a large study in JAMA Internal Medicine from 2015 found a significant association between higher cumulative anticholinergic use and an increased risk for dementia, with tricyclic antidepressants being a commonly used class.
Speaker 2
That's a serious consideration. While nortriptyline might have fewer anticholinergic side effects than some other TCAs, the cumulative impact is still relevant. The challenge is balancing the proven benefit of pain relief against potential long-term cognitive risks.
Speaker 1
And what's still unknown? We've got evidence linking anticholinergics to dementia risk, and chronic pain to accelerated aging, but direct, long-term studies specifically on nortriptyline's effect on biological aging markers or all-cause mortality are less clear.
Speaker 2
Right. We don't have definitive evidence showing nortriptyline directly accelerates epigenetic aging or impacts all-cause mortality in the same way we see the dementia link. It's a complex picture requiring careful individual consideration with a healthcare provider.
Read the Nortriptyline monograph → Explore the Pathway Universe  🌌 ← All episodes

Educational research discussion only — not medical advice. Statements have not been evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to a qualified clinician before changing any treatment.